Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid in elderly patients with Gram-positive complicated skin/soft tissue infection or pulmonary infection
ChiCTR2400086801Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of contezolid in skin and soft tissue infections (SSTIs), hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) and 1 more (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Safety. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
contezolid
03
Conditions
skin and soft tissue infections (SSTIs)hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)Gram-positive bacterial infection
Beyond the preview
Go deeper on ChiCTR2400086801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086801.